글로벌 디지털 유방 단층촬영 시장 – 2030년까지의 산업 동향 및 예측

 디지털 유방 단층 합성 시장 분석 및 규모

유방암은 여성에게 가장 흔한 암 유형 중 하나로, 2018년 전 세계적으로 약 627,000명의 여성에게 영향을 미쳤습니다. 전 세계 생존율은 진단 시간과 비율, 서비스의 가용성과 경제성에 따라 다릅니다. 전 세계적으로 더 나은 암 탐지 시설을 제공하기 위한 R&D 투자가 증가하면서 디지털 유방 단층촬영술 산업에 대한 투자가 증가했습니다. 건강 의식의 증가와 기술 발전은 산업 성장에 추가적인 원동력을 제공하고 있습니다.

Data Bridge Market Research는 2022년에 23억 4천만 달러 규모였던 디지털 유방 단층촬영술 시장이 2030년까지 64억 4천만 달러 규모로 성장할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 연평균 성장률은 13.5%에 이를 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

디지털 유방 단층촬영술 시장 범위 및 세분화  

시장 정의

Breast tomosynthesis mammography (also known as "3D" mammography) is a type of mammography that has grown in popularity in recent years. It is an x-ray imaging exam in which numerous photographs of the breast are taken. The breast is crushed similarly to how it would be in standard mammography. The x-ray tube moves around the breast in an arc, collecting images from various angles. The x-ray images are displayed as a stack of mammography images for the radiologist to read.

Digital Breast Tomosynthesis Market Dynamics

Drivers

• Rise in breast cancer cases

According to the World Health Organization (WHO), breast cancer affected approximately 627,000 women worldwide in 2018. It is also estimated that the disease occurrence is higher in developed regions than in developing regions. Disease screening with DBT is far more convenient and efficient than 2D mammography, so demand for such products is expected to rise during the forecast period.

• Government Initiatives

At the national, regional, and local levels, various government, public, private, advocacy, and community group breast cancer education and awareness initiatives are ongoing. Early detection and diagnosis programmes are an essential component of these initiatives. For instance, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which is overseen by the Centers for Disease Control and Prevention, assists women in making breast and cervical cancer screening more accessible. This programme assists women who cannot afford these services or do not have insurance that coversdo not cover them.

Opportunities

• Technological advancements

Technological advancements can be identified as significant driver for this market. DBT reduces the likelihood that women will need to return for additional breast imaging by about 15%, lowering both costs, psychological distress, time, and discomfort caused by a false negative recall. It improves cancer detection by increasing specificity and sensitivity by reducing false positive recalls. Breast cancer detection has significantly improved with the combination of 2-D and 3-D mammography because it allows the mammary glands to appear in thin slices and detect hidden cancers in the breast. These are the certain factors which propel the market growth.

Restraints/Challenges

• High cost of the equipment

The availability of alternatives will be major restraint on the digital breast tomosynthesis market. DBT has a number of potential limitations and practical disadvantages. DBT may result in higher radiation doses, longer scan times, longer reading times, and other risks. Such issues are likely to hamper the market growth.

This digital breast tomosynthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital breast tomosynthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Digital Breast Tomosynthesis Market

COVID-19 has affected the entire world and has had a significant impact on the healthcare system. This outbreak has significantly impacted the digital breast tomosynthesis equipment market. The pandemic significantly reduced breast cancer screening, cancer management visits, and cancer procedures worldwide. The strict lockdown and policies caused the relocation of medical healthcare providers and material resources, causing the healthcare providers to focus primarily on this sudden emergency, postponing other non-emergency medical services. As a result, most medical centres have ceased performing elective and non-emergency procedures. However, the market experienced significant growth within a few months due to increased demand for these procedures.

Recent Developments

• In 2022, Hologic, Inc. announced  opening its innovation centre in France. This new facility will enhance its ultrasound, interventional, and surgical solutions across the breast healthcare business.
• In 2022, Unilabs and GE Healthcare signed a partnership agreement. Unilabs in Portugal receives technically advanced MRIs and CT scanning technology, ultrasound devices, mammography, and X-ray machines from GE Healthcare.

Global Digital Breast Tomosynthesis Market Scope

The digital breast tomosynthesis market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• 2D/3D Combination Systems
• Standalone 3D Systems

 End User

• Hospitals
• Diagnostic Centres
• Others

Digital Breast Tomosynthesis Market Regional Analysis/Insights

The digital breast tomosynthesis market is analyzed and market size insights and trends are provided by country, product and end user as referenced above.

The countries covered in the digital breast tomosynthesis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the digital breast tomosynthesis market due to the rise in the prevalence of breast cancer. Furthermore, the rise in healthcare costs will fuel the region's digital breast tomosynthesis market growth during the forecast period.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the occurrence of major key players in the emerging countries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The digital breast tomosynthesis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital breast tomosynthesis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital breast tomosynthesis market. The data is available for historic period 2011-2021.

Competitive Landscape and Digital Breast Tomosynthesis Market Share Analysis

The digital breast tomosynthesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital breast tomosynthesis market.

Some of the major players operating in the digital breast tomosynthesis market are:

• Siemens (Germany)
• Hologic, Inc. (U.S.)
• 심천 Mindray Bio-Medical Electronics Co., Ltd. (중국)
• 애벗(미국)
• BD(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• Thermo Fisher Scientific Inc. (미국)
• Koninklijke Philips NV(네덜란드)
• Shimadzu Medical (India) pvt. Ltd. (일본)
• 제너럴 일렉트릭(미국)
• Quest Diagnostics Incorporated(미국)
• Sysmex India Pvt. Ltd.(일본)
• 히타치 주식회사(일본)
• 캐논 주식회사(일본)
• 후지필름 홀딩스 코퍼레이션(영국)

SKU-50404